Efficacy of brahmi vati and ashwagandharishta in (chittodwega) generalized anxiety disorder- Randomized controlled clinical trail
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 68
- 试验地点
- 1
- 主要终点
- Improvement in the Hamilton Anxiety Scale score, WHO- Quality of Life,
研究概览
简要总结
anxiety is normal and common process of stress.it is beneficial at time and harmful of health at time. on the beneficial side, anxiety alerts certain dangers and dangerous situation. which we might tentatively confront and helps us to prepare and pay attention to it.
anxiety disorders are the most common of mental disorders .they affect approximately 30% of adults at some part of their lives. these disorders are harmful for our heath . they differ from normal feelings of anxiousness and nervous ness . they involve excessive fear and anxiety . at the same time ,these disorders can be treated as there are many treatment options to deal with them .women are likely to experience these disorders more than man
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients fulfilling the HAM-A Scale and QOL (Quality of Life) Assessment Criteria for Generalized Anxiety Disorder.
- •Age group between 16-60 years.
排除标准
- •EXCLUSION CRITERIA [19]
- •Patients presenting with Major Organic Disorders and Psychotic Disorders
- •Patients below 16 years of age and above 60 years
- •Alcoholic, and self-harm or suicide risk.
- •Diagnosed with psychosis, schizophrenia, or bipolar illness currently or in the past.
- •Treatment with sertraline for two or more weeks within the previous three months.
- •Pregnant and lactating mothers.
结局指标
主要结局
Improvement in the Hamilton Anxiety Scale score, WHO- Quality of Life,
时间窗: 0, 30, 60
次要结局
- not applicable(not applicable)
研究者
Anjali punia
desh bhagat university